Public Health Wales Primary Care Quality Minimising the Harms of Polypharmacy 1Learning 2 Specific learning points 3. Number of cases with these 4. Action prompted 5. Action themes (expressed as fraction of Point Themes identified in each case at practice level prompted at – the medication reviews e.g. cluster level 4/15) Testing and Monitoring Evidence and Guidelines Adverse Events Risk Reduction or prevention or Switching Page 11 November 2015 Version: Final v1
Public Health Wales Primary Care Quality Minimising the Harms of Polypharmacy 1Learning Point Themes 2 Specific learning points identified in each case 3. Number of cases with these themes (expressed as fraction of the medication reviews – e.g. 4/15) 4. Action prompted at practice level 5. Action prompted at cluster level Testing and Monitoring Evidence and Guidelines Adverse Events Risk Reduction or prevention or Switching November 2015 Version: Final v1 Page 11
FinalPolypharmacyGuidance%202015%20%282%29.docx